223 related articles for article (PubMed ID: 32037821)
1. Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury.
Mosedale M; Watkins PB
J Med Chem; 2020 Jun; 63(12):6436-6461. PubMed ID: 32037821
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and Bioactivation: It's Time to Expect the Unexpected.
Driscoll JP; Sadlowski CM; Shah NR; Feula A
J Med Chem; 2020 Jun; 63(12):6303-6314. PubMed ID: 32267691
[TBL] [Abstract][Full Text] [Related]
3. Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.
Shaw PJ; Ganey PE; Roth RA
Toxicol Sci; 2010 Nov; 118(1):7-18. PubMed ID: 20538741
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of immune-mediated liver injury.
Adams DH; Ju C; Ramaiah SK; Uetrecht J; Jaeschke H
Toxicol Sci; 2010 Jun; 115(2):307-21. PubMed ID: 20071422
[TBL] [Abstract][Full Text] [Related]
5. Idiosyncratic drug hepatotoxicity.
Kaplowitz N
Nat Rev Drug Discov; 2005 Jun; 4(6):489-99. PubMed ID: 15931258
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation in drug-induced liver injury.
Leung L; Kalgutkar AS; Obach RS
Drug Metab Rev; 2012 Feb; 44(1):18-33. PubMed ID: 21939431
[TBL] [Abstract][Full Text] [Related]
7. On mechanisms of reactive metabolite formation from drugs.
Claesson A; Spjuth O
Mini Rev Med Chem; 2013 Apr; 13(5):720-9. PubMed ID: 23035789
[TBL] [Abstract][Full Text] [Related]
8. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.
Thompson RA; Isin EM; Ogese MO; Mettetal JT; Williams DP
Chem Res Toxicol; 2016 Apr; 29(4):505-33. PubMed ID: 26735163
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models.
Deng X; Luyendyk JP; Ganey PE; Roth RA
Pharmacol Rev; 2009 Sep; 61(3):262-82. PubMed ID: 19805476
[TBL] [Abstract][Full Text] [Related]
10. Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic).
Iasella CJ; Johnson HJ; Dunn MA
Clin Liver Dis; 2017 Feb; 21(1):73-87. PubMed ID: 27842776
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.
Mosedale M; Watkins PB
Clin Pharmacol Ther; 2017 Apr; 101(4):469-480. PubMed ID: 27861792
[TBL] [Abstract][Full Text] [Related]
12. Predicting toxicities of reactive metabolite-positive drug candidates.
Kalgutkar AS; Dalvie D
Annu Rev Pharmacol Toxicol; 2015; 55():35-54. PubMed ID: 25292426
[TBL] [Abstract][Full Text] [Related]
13. Minimising the potential for metabolic activation in drug discovery.
Kalgutkar AS; Soglia JR
Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):91-142. PubMed ID: 16922655
[TBL] [Abstract][Full Text] [Related]
14. Unraveling cellular pathways contributing to drug-induced liver injury by dynamical modeling.
Kuijper IA; Yang H; Van De Water B; Beltman JB
Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):5-17. PubMed ID: 27609146
[TBL] [Abstract][Full Text] [Related]
15. Models of Idiosyncratic Drug-Induced Liver Injury.
Yokoi T; Oda S
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():247-268. PubMed ID: 32976738
[TBL] [Abstract][Full Text] [Related]
16. Idiosyncratic toxicity: a convergence of risk factors.
Ulrich RG
Annu Rev Med; 2007; 58():17-34. PubMed ID: 16958561
[TBL] [Abstract][Full Text] [Related]
17. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges.
Jee A; Sernoskie SC; Uetrecht J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799477
[TBL] [Abstract][Full Text] [Related]
18. Research Progress on the Animal Models of Drug-Induced Liver Injury: Current Status and Further Perspectives.
Pan Y; Cao M; You D; Qin G; Liu Z
Biomed Res Int; 2019; 2019():1283824. PubMed ID: 31119149
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced liver injury.
Kaplowitz N
Clin Infect Dis; 2004 Mar; 38 Suppl 2():S44-8. PubMed ID: 14986274
[TBL] [Abstract][Full Text] [Related]
20. The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury.
Woodhead JL; Watkins PB; Howell BA; Siler SQ; Shoda LKM
Drug Metab Pharmacokinet; 2017 Feb; 32(1):40-45. PubMed ID: 28129975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
